Common Medications in Critical Care: Part 1 - No Test
Hours: 1.50
Many medications are used in the critical care setting. A comprehensive assessment of a patient’s clinical status, comorbid conditions, and current medications is necessary before additional interventions are applied. All medical interventions should be evidence-based, goal-directed therapy. Because critical care pharmacotherapy literature evolves rapidly, practitioners must be vigilant to stay up to date with new guidelines and best practices.
Many medications are used in the critical care setting. A comprehensive assessment of a patient’s clinical status, comorbid conditions, and current medications is necessary before additional interventions are applied. All medical interventions should be evidence-based, goal-directed therapy. Because critical care pharmacotherapy literature evolves rapidly, practitioners must be vigilant to stay up to date with new guidelines and best practices.
California Board of Registered Nursing
Provider approved by the California Board of Registered Nursing, CEP# 13791
Nurses will receive 1.50 contact hours for participating in this course.
American Nurses Credentialing Center
In support of improving patient care, Relias LLC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Nurses will receive 1.50 Nursing Contact Hours after successfully completing this course.
Recognize the role of cardiovascular and hemostatic agents in critical care.
Recall indications, common adverse effects, and contraindications for cardiac medications.
Identify three classes of drugs used in the pharmacological management of cardiovascular and hemostatic treatment.
Outline:
Section 1: Introduction
About This Course
Learning Objectives
Section 2: Vasopressors and Inotropes
Overview
Pure Vasopressors
Inopressors
Inodilators
New Vasopressor Agents
Section 3: Antihypertensives
β-Adrenergic Receptor Blockers
Calcium Channel Blockers (CCBs)
Angiotensin-Converting Enzyme (ACE) Inhibitors
Other Agents
Vasodilators
Pulmonary Vasodilators
Section 4: Anti-Arrhythmics
Overview
Class 0: Hyperpolarization-Activated Cyclic Nucleotide-Gated (HCN) Channel Blockers
Class I: Voltage-Gated Sodium Channel Blockers
Class II: Autonomic Inhibitors and Activators
Class III: Potassium Channel Blockers and Openers
Class IV: Calcium Channel Modulators
Class V: Mechanosensitive Channel Blockers
Class VI: Gap Junction Channel Blockers
Class VII: Upstream Target Modulators
Section 5: Hemostatic Drugs
Overview
Anticoagulants
Antiplatelet Drugs
Thrombolytics
Antifibrinolytics and Hemostatic Agents
Section 6: Conclusion
Course Summary
Course Contributors
References
Writer: Emily Allen
Reviewer: Derek J. Gyllenhammer, PharmDShe started nursing in 2012 after graduating with an Accelerated BSN from NC Central University in Durham, North Carolina. She is an experienced Ambulatory and Perianesthesia Care RN, with an endoscopy lab and orthopedics nursing background. She has served as a PACU charge nurse and is a Certified Peri-Anesthesia Nurse (CPAN) from the ABPANC (American Board of Perianesthesia Nursing Certification). Her experience and knowledge led her to nursing education, preceptoring experienced new hires and nursing students while working to receive her MSN in Nurse Education at UNC Wilmington. As a PACU RN, she has cared for a wide variety of patients, including medical-surgical inpatient and ambulatory surgical patients. Her passion for education and training has led her to a position as a content writer at Relias.
Derek J. Gyllenhammer, PharmD, is a community pharmacist from the Hartford, Connecticut, area. He graduated with his Doctor of Pharmacy from the University of Connecticut in 2016.
Asynchronous/Online Distance Learning; please see certificate details for specifics on delivery format.
Relias has a grievance policy in place to facilitate reports of dissatisfaction. Relias will make every effort to resolve each grievance in a mutually satisfactory manner. In order to report a complaint or grievance please contact Relias.
If you require special accommodations to complete this module, please contact Relias Support by completing the web form (https://www.relias.com/help) or by using the chat functionality.
All courses offered by Relias, LLC are developed from a foundation of diversity, inclusiveness, and a multicultural perspective. Knowledge, values and awareness related to cultural competency are infused throughout the course content.
Reference herein to any specific commercial product, process, or service by trade name, trademark, service mark, manufacturer or otherwise does not constitute or imply any endorsement, recommendation, or favoring of, or affiliation with, Relias, LLC.
All characteristics and organizations referenced in the following training are fictional. Any resemblance to any actual organizations or persons living or dead, is purely coincidental.
To earn continuing education credit for this course you must achieve a passing score of 80% on the post-test and complete the course evaluation.
If you require special accommodations to complete this module, please contact Relias Customer Support here.
